Ginkgo Bioworks Holdings Inc logo

DNA

Ginkgo Bioworks Holdings Inc

$1.71

Earnings Summary

Revenue
$168.41Mn
Net Profits
$-590.51Mn
Net Profit Margins
-350.65%

Highlights

Revenue:

Ginkgo Bioworks Holdings Inc’s revenue jumped 281.9% since last year same period to $168.41Mn in the Q1 2022. On a quarterly growth basis, Ginkgo Bioworks Holdings Inc has generated 13.41% jump in its revenue since last 3-months.

Net Profits:

Ginkgo Bioworks Holdings Inc’s net profit fell -10348.98% since last year same period to $-590.51Mn in the Q1 2022. On a quarterly growth basis, Ginkgo Bioworks Holdings Inc has generated 63.11% jump in its net profits since last 3-months.

Net Profit Margins:

Ginkgo Bioworks Holdings Inc’s net profit margin fell -2783.7% since last year same period to -350.65% in the Q1 2022. On a quarterly growth basis, Ginkgo Bioworks Holdings Inc has generated 67.47% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Ginkgo Bioworks Holdings Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.16
EPS Estimate Current Year
-0.16

Highlights

EPS Estimate Current Quarter:

Ginkgo Bioworks Holdings Inc’s earning per share (EPS) estimates for the current quarter stand at -0.16 - a 43.36% jump from last quarter’s estimates.

EPS Estimate Current Year:

Ginkgo Bioworks Holdings Inc’s earning per share (EPS) estimates for the current year stand at -0.16.

Key Ratios

Key ratios of the Ginkgo Bioworks Holdings Inc post its Q4 2022 earnings

Earning Per Share (EPS)
0

Highlights

Earning Per Share (EPS):

Ginkgo Bioworks Holdings Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q4 2022. This indicates that the Ginkgo Bioworks Holdings Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-08-01
-0.04
-0.41
-846.88%
2022-11-01
-0.28
0
100%
2022-05-16
-0.14
-0.37
-158.02%
2023-03-28
-0.16
0
100%

Company Information

Ginkgo Bioworks is building a platform to enable customers to program cells as easily as they can program computers. The company's cell programming platform enables the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals.

Organisation
Ginkgo Bioworks Holdings Inc
Headquarters
27 Drydock Avenue, Boston, MA, United States, 02210
Employees
641
Industry
Healthcare

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*